Upfront Cranial Radiotherapy vs. EGFR Tyrosine Kinase Inhibitors Alone for the Treatment of Brain Metastases From Non-small-cell Lung Cancer: A Meta-Analysis of 1465 Patients-Reference-Cited by-同舟云学术

Upfront Cranial Radiotherapy vs. EGFR Tyrosine Kinase Inhibitors Alone for the Treatment of Brain Metastases From Non-small-cell Lung Cancer: A Meta-Analysis of 1465 Patients

Published:2018-12-12 Issue: Volume:8 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Du Xiao-Jing,Pan Su-Ming,Lai Shu-Zhen,Xu Xiao-Nan,Deng Mei-Ling,Wang Xiao-Hui,Yao Dun-Chen,Wu Shao-Xiong

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference36 articles.

1. Correlation between EGFR mutation status and the incidence of brain metastases in patients with non-small cell lung cancer;Li;J Thorac Dis.,2017

2. Brain metastases from NSCLC: radiation therapy in the era of targeted therapies;Khalifa;J Thorac Oncol.,2016

3. Diagnosis and treatment of brain metastases from solid tumors: guidelines from the european association of neuro-oncology (EANO);Soffietti;Neuro Oncol.,2017

4. Metastatic non-small-cell lung cancer (NSCLC): ESMO clinical practice guidelines for diagnosis, treatment and follow-up;Reck;Ann Oncol.,2014

5. Epidermal growth factor receptor tyrosine kinase inhibitors as a first-line therapy for never-smokers with adenocarcinoma of the lung having asymptomatic synchronous brain metastasis;Kim;Lung Cancer,2009

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intracranial Outcomes of De Novo Brain Metastases Treated With Osimertinib Alone in Patients With Newly Diagnosed EGFR-Mutant NSCLC;JTO Clinical and Research Reports;2023-12

2. First-line treatment with TKI plus brain radiotherapy versus TKI alone in EGFR-mutated non-small cell Lung cancer with brain metastases: a systematic review and meta-analysis;BMC Cancer;2023-10-30

3. Effect of Different Timing of Local Brain Radiotherapy on Survival of EGFR-Mutated NSCLC Patients with Limited Brain Metastases;Brain Sciences;2023-09-03

4. Experimental study of EGFR-TKI aumolertinib combined with ionizing radiation in EGFR mutated NSCLC brain metastases tumor;European Journal of Pharmacology;2023-04

5. Treatment outcomes of EGFR-TKI with or without locoregional brain therapy in advanced EGFR-mutant non-small cell lung cancer patients with brain metastases;Współczesna Onkologia;2023